Intestinal cryptosporidiosis: a complication of cancer treatment.
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001855:Bone Marrow Diseases / Q000188:drug therapy; D001943:Breast Neoplasms / Q000628:therapy; D003131:Combined Modality Therapy; D003457:Cryptosporidiosis / Q000139:chemically induced* / Q000188:drug therapy / Q000469:parasitology; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005243:Feces / Q000469:parasitology; D005260:Female; D006801:Humans; D007410:Intestinal Diseases / Q000139:chemically induced* / Q000188:drug therapy / Q000469:parasitology; D007933:Leucomycins / Q000627:therapeutic use; D008207:Lymphatic Metastasis; D008223:Lymphoma / Q000188:drug therapy; D011241:Prednisone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D007933:Leucomycins; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone